✉: pharma@stmjournals.com📞: +91 120 478 1209
ae5c6bd4 drug design discovery scaled

Research & Reviews: A Journal of Drug Design & Discovery

2349-9036 Peer‑Reviewed | Subscription‑Based

rrjoddd Volume: 11, Issue: 01 Year: 2024

5

Regular Issue  Subscription Review Article Published on :- Apr 15, 2024
By  

 

Chenna M Shalini, Asireddy Sathvika Reddy, Vallarapu Nanda Krishna Veni, Madhira Jayaprakash, Rama Rao T,
Abstract : Fast-dissolving oral thin films (FDOFs) represent a significant advancement in drug delivery technology, offering advantages over traditional solid read more

[This section belongs to Research & Reviews: A Journal of Drug Design & Discovery (rrjoddd)]

 

 

24-31
Regular Issue  Subscription Original Research Published on :- Apr 15, 2024
By  

 

Prosenjit Dutta, Lata Khani Bisht, Vineeth Chandy,
Abstract : Natural compounds are increasingly explored for their therapeutic potential in medical research. Here, we focused on demethoxycurcumin (DMC), a read more

[This section belongs to Research & Reviews: A Journal of Drug Design & Discovery (rrjoddd)]

 

 

9-15
Regular Issue  Subscription Original Research Published on :- Apr 15, 2024
By  

 

Patil Divyashree Kantilal, Patil Bhagyshri Sandip, Patil Bhushan Ravindra, Patil Divyani Rajendra,
Abstract : The landscape of clinical research quality management has evolved significantly in recent years, driven by stringent regulatory frameworks and read more

[This section belongs to Research & Reviews: A Journal of Drug Design & Discovery (rrjoddd)]

 

 

1-8
Regular Issue  Subscription Review Article Published on :- Apr 15, 2024
By  

 

Chhatrapalsinh R. Parmar, Pratiksha N. Patil, Riddhi S.Bhavsar, Rohitkumar D.Shah, Riya A.Rajput,
Abstract : One of the most prevalent metabolic disorders is osteoporosis (OP), which primarily affects postmenopausal women and the elderly. It is often read more

[This section belongs to Research & Reviews: A Journal of Drug Design & Discovery (rrjoddd)]

 

 

16-23
Regular Issue  Subscription Original Research Published on :- Apr 15, 2024
By  

 

Bhaveshkumar Patel,
Abstract : There are several medicinal agents available for antihypertensive activity. Telmisartan, metoprolol and cilnidipine are among them. Quantitative and read more

[This section belongs to Research & Reviews: A Journal of Drug Design & Discovery (rrjoddd)]

 

 

32-38

Editorial Board

View Full Editorial Board

rrjoddd maintains an Editorial Board of practicing researchers from around the world, to ensure manuscripts are handled by editors who are experts in the field of study.

Editor in Chief

Editor

Dr. Sidhartha Sankar Kar, Professor & HOD

School of Pharmacy, DRIEMS University, Cuttack, Odisha, India, 754022

Email :